Palladyne AI ($PDYN): Can New Orders Build Lasting Growth?

01 Three scenarios for the next operating update

Bull case: orders become revenue while cash consumption falls

The constructive case starts with a real delivery business. Palladyne reported $24.6 million of backlog at June 30, 2026, and approximately $13 million of new awards during the quarter, against quarterly revenue of $5.783 million. Management reiterated 2026 revenue guidance of $24–27 million on August 6. That gives the company work to execute rather than a thesis resting entirely on demonstrations. The next improvement would be a combination of deliveries, repeat orders and lower cash consumption as the enlarged business absorbs its operating costs. Source Source

For the year ending December 31, 2026, the revenue guidance requires a calculated $14.679–17.679 million in second-half sales after the first half’s $9.321 million. That is a meaningful acceleration, and the favorable case is stronger if the increase arrives across consecutive quarters instead of being concentrated in a late shipment. A growing contribution from software product sales would add evidence that the technology can generate revenue beyond customer-funded development and the businesses acquired in November 2025. Source Source

FANUC America, NORDA Dynamics and Orkid create routes to potential customers; they do not determine the revenue outcome by themselves. A paid deployment or a follow-on contract would carry more financial weight than another integration announcement. The bullish interpretation also needs the improvement to reach existing shareholders: slower dilution and lower consumption of cash would support that conclusion. These are operating conditions, not a price objective.

Base case: commercial progress with continuing financing needs

The central case is an expanding defense and industrial supplier whose economics remain immature. For the six months ended June 30, 2026, operating cash outflow plus capital expenditure totaled a calculated $21.290 million. Revenue can grow quickly from a small base while the organization continues to consume substantial cash. Engineering, manufacturing, business development and software investment compete for the same liquidity. Source

In this scenario the backlog supports more deliveries, partnerships progress at different speeds, and software monetization remains gradual. Equity issuance continues to provide flexibility. That can sustain the business without producing the same rate of improvement in revenue or cash per share. The June-quarter balance sheet offers time to execute, but it does not remove the need to compare each subsequent capital raise with the commercial progress it finances.

The base case would be confirmed by a reasonable revenue increase accompanied by continued losses, uneven working-capital movements and additional share issuance. It would improve if cash usage declines without cutting the activities required to deliver contracted work. It would weaken if the annual revenue ambition becomes increasingly dependent on orders that have not yet turned into enforceable customer commitments.

Bear case: the commercial ramp is slower than the spending ramp

The adverse case is a timing mismatch. Staff, equipment and development expenditures are paid before customers accept systems or expand orders. Delayed procurement or integration then pushes revenue out while expenses continue. At June 30, 2026, the company had $43.746 million of cash and marketable securities, but its historical first-half burn rate implies only about 12.3 months of static coverage. That calculation is a sensitivity, not management’s forecast of the date cash will run out. Source

A second risk is that the market treats collaborations as large orders and values the group as a mature software business. The June 2026 report explicitly states that software product sales had not yet produced revenue. The company does earn money through development contracts, hardware and engineering; those activities have different margins, delivery risks and capital requirements. Disappointment can therefore occur even if the technology works as described. Source

The negative case strengthens if cash consumption fails to fall, backlog conversion slows, or new equity becomes the main reason liquidity remains stable. It would be contradicted by repeat commercial adoption, a durable improvement in cash flow and growth that comfortably exceeds the increase in shares. Short positioning can amplify the response to either outcome, but it does not settle which outcome is more likely.

What Would Falsify This Reading

This reading changes when operating evidence changes. Partnership names and share-price moves alone do not settle the commercial or funding questions.

• Cash improvement reaches the business. Lower operating outflow and capex, supported by collections rather than mainly new equity, would weaken the financing-risk case. The comparison is the $21.290 million first-half 2026 burn calculated from the cash-flow statements. Source
• Software becomes a commercial revenue stream. The June 2026 report says software product sales had not generated revenue. Repeat paid adoption with a clear gross-profit contribution would strengthen the commercial thesis. Source
• Backlog conversion misses the required pace. Delayed deliveries, weaker replacement awards or a reduction in the August 6 annual revenue outlook would challenge the growth case. June backlog includes funded and unfunded commitments. Source Source
• More capital buys less progress. If the share count grows while burn remains elevated and customer conversion slows, liquidity preservation would be a weaker result for existing holders. The July 29, 2026 company share count is 49,338,510. Source

These are observations that would weaken the interpretation, not forecasts of inevitable events.

02 What Palladyne sells and what the AI label leaves out

Palladyne AI combines autonomy software with avionics, engineering and precision manufacturing. The June 30, 2026 report describes Palladyne IQ for industrial robots and SwarmOS/Palladyne Pilot for autonomous systems. In practical terms, the software is intended to help machines adapt to changing conditions and coordinate activity rather than simply follow a fixed sequence. The investment question is whether customers pay for those capabilities repeatedly and at an attractive margin. Source

The business changed materially with the November 14, 2025 acquisitions of GuideTech, Warnke Precision Machining and MKR Fabricators. GuideTech brought aerospace engineering and avionics; the other operations brought manufacturing and fabrication. The June 2026 report records aggregate purchase consideration of approximately $22.6 million, including cash, shares and the initial fair value of contingent consideration. These acquired operations are part of the growth comparison, so the headline increase is not a clean measure of organic software adoption. Source

For the quarter ended June 30, 2026, reported revenue comprised $2.691 million of products, $1.179 million of product-development contracts and $1.913 million of engineering services. The product category included hardware and manufactured components. The same report states that software product revenue had not yet begun. That distinction does not mean the software has no customers or no development funding; it means funded development and commercial software licensing are different revenue sources. Source

The enlarged model has advantages. An engineering team can help integrate software, while manufacturing can turn an opportunity into a physical deliverable. It also makes the company more demanding to finance. Production requires materials, equipment and quality assurance; engineering often requires people before a program produces cash. A software label does not make those obligations disappear.

The first commercial software revenues would therefore be useful evidence, but their size and character would matter. A one-off license associated with integration work would not establish a recurring subscription business. Repeat deployments, customer expansion and a clear contribution to gross profit would be stronger signals. Until then, Merlintrader’s reading is that Palladyne is best described as a developing defense and industrial supplier with potentially valuable software, rather than a business whose group revenue carries the economics of a mature software platform.

The 10-Q also sets out how early the product range still is. It describes Palladyne IQ, Palladyne Pilot, SwarmOS, BRAIN and IntelliSwarm as being “in the early stages of commercialization”, still undergoing reliability testing and debugging, while the Gremlin-X and SwarmStrike drones “are still in initial product development”. The company’s own risk factors add that it has “no previous history with our licensing sales model for our software products”. Source

Field evidence so far comes from Army experimentation rather than procurement. On August 6 the company said SwarmOS had coordinated drones from several manufacturers under a single operator at the 4th Infantry Division’s Ivy Mass rehearsal and then at Project Convergence Capstone 6, including integration with Anduril’s Lattice platform. Those are the company’s descriptions of test events; they carry no disclosed contract value. On August 10 Palladyne added retired Maj. Gen. Mark A. Clark, a former MARSOC commander and USSOCOM chief of staff, to its defense advisory board. Source Source

03 Quarterly results: rapid growth, a larger operating loss

Palladyne’s revenue reached $5.783 million in the quarter ended June 30, 2026, compared with $1.015 million a year earlier. Using the first half’s $9.321 million and subtracting the June quarter gives a calculated $3.538 million for the March quarter; the sequential increase was approximately 63.5%. These are substantial gains, but management attributes growth to “both acquisitions and organic growth”, so the percentages are not a measure of organic expansion. The preliminary figures published on July 8 had indicated growth of about 480% year over year and 66% sequentially; the final report showed 470% and 63%. Source Source

The revenue gain did not yet produce operating leverage sufficient to cover the cost base. Operating loss was $13.413 million in the June 2026 quarter versus $8.094 million in the June 2025 quarter. Research and development, sales and marketing, and general and administrative expenses all increased. The growth strategy therefore requires more than a higher sales line: additional gross profit has to outpace the cost of building and supporting the organization. Source

Revenue less the separately reported cost-of-revenue line was a calculated $1.681 million in the June 2026 quarter, or approximately 29.1% of sales, before the separately presented intangible-amortization expense. The calculation is useful for seeing how much revenue remains to fund operating expenses, but it should not be confused with an all-in profitability measure. The acquired mix and the type of contract delivered can move that contribution considerably between quarters. Source

The June 2026 quarterly net loss was $12.326 million, or $0.27 per share, and included a $0.814 million noncash gain from warrant revaluation. Stock compensation was $2.319 million in the same quarter. Management’s adjusted loss removes specified accounting items, but operating cash flow is the more direct test of how much funding the business consumes. An accounting gain on a warrant liability cannot pay an engineer or purchase inventory. Source

The first-half revenue mix also shows where growth did not come from. Product-development contract revenue, which the 10-Q defines as contracts “to develop, design and modify our technology and related products”, fell from $2.722 million in the first half of 2025 to $1.246 million in the first half of 2026. The company attributes the decline “primarily” to fewer new contracts and less funding in the first quarter “due to government delays and shutdowns”, partly offset by new awards in the second quarter. Engineering services ($3.693 million in the half) come from one of the businesses acquired in November 2025. Source

What deserves attention in the next results is the combination of revenue mix, cash collection and expenses. More engineering work can support sales without immediately validating software margins. Product deliveries can lift reported revenue while building receivables. Strong bookings can precede the associated expenditure. A useful quarter would explain all three movements instead of relying on the growth percentage alone.

04 Backlog, options and the revenue needed in the second half

The final June 30, 2026 backlog was $24.6 million. It supersedes the approximately $24 million preliminary figure discussed in July. The final quarterly release also reported approximately $13 million of new contract awards during the June quarter. The company expected most of the backlog to convert to revenue over the following 12–18 months, so it cannot all be treated as revenue due before the end of 2026. Three months earlier, the March-quarter report had put backlog at $17.3 million and expected most of it to be recognized over the next 12 months; the June figure is about 42% higher on Merlintrader’s calculation from the rounded amounts (the company states 43%), while the conversion window quoted by the company has lengthened. Source Source

The definition matters: backlog includes committed contracts and purchase orders, both funded and unfunded, less revenue already recognized. It is a better indication of actual commercial work than a partnership announcement, but it is not a cash balance. Delivery, funding and customer acceptance can affect when the work produces revenue and when that revenue becomes cash. Source

At June 30, 2026, the company’s broader total contract value was $30.9 million, including estimated potential value from unexercised options on existing firm contracts, up from $23.4 million at March 31 and $20.0 million at December 31, 2025. That figure includes backlog rather than sitting on top of it. Adding the two would double count the contracted base. The extra option value is contingent on future customer decisions; it is not equivalent to a newly exercised order. Source

The August 6 guidance of $24–27 million for full-year 2026, less first-half revenue of $9.321 million, implies second-half revenue of $14.679–17.679 million. Spread evenly, that would be approximately $7.34–8.84 million per quarter, compared with the June quarter’s $5.783 million. This is a calculation illustrating the required pace, not new guidance or a forecast that the quarters will be equal. Source Source

A useful next update would identify which work supports that acceleration and how much depends on new awards. It would also explain whether backlog replenishment keeps up with revenue recognition. A declining backlog can be healthy when deliveries accelerate, but it becomes a concern if replacement orders weaken at the same time. Conversely, a higher backlog is less reassuring if conversion repeatedly slips and working capital absorbs more cash.

The practical test is whether management can connect booked work, expected deliveries and available capacity. This makes an exercised contract option more meaningful than an enlarged addressable market, and makes cash collection more meaningful than simply repeating the total value of a program.

05 Cash, monthly burn and the runway calculation

At June 30, 2026, Palladyne reported $33.774 million of cash and cash equivalents and $9.972 million of marketable securities, a combined $43.746 million. The securities were U.S. Treasury securities. The comparable combined balance at December 31, 2025 was $47.055 million. Cash alone rose during the first half partly because securities matured; that internal change does not represent new customer cash generation. Source

For the six months ended June 30, 2026, cash used in operations was $20.401 million and purchases of property and equipment were $0.889 million. Adding those amounts gives $21.290 million, or approximately $3.548 million per month. This uses management’s definition of operating cash burn: operating cash outflow plus capital expenditure. The $0.100 million received from selling equipment is shown separately and has not been used to reduce this calculation. Source Source

Dividing June 30 liquidity of $43.746 million by that historical monthly burn produces approximately 12.3 months of static coverage. The inputs are dated June 2026; the result is not a cash forecast as of October and not an estimated insolvency date. It assumes unchanged spending and collections, no new funding and no other use of capital. A company that is changing its delivery mix can depart materially from those assumptions. Source

The quarterly comparison reinforces why the annual average needs context. March 2026 operating cash use was $10.239 million with $0.027 million of capex, giving $10.266 million of company-defined burn. Subtracting those figures from the first half produces calculated June-quarter burn of $11.024 million, or about $3.675 million per month. Cash consumption increased even as revenue grew. Source Source

Management reiterated full-year 2026 burn guidance of $32–36 million on August 6. After the first half’s calculated $21.290 million, that implies $10.710–14.710 million for the second half, equivalent to approximately $1.785–2.452 million per month. This is the key improvement embedded in the outlook: the second half must consume meaningfully less cash than the first. The company attributed the expected improvement to higher revenue and margins after investment in staff and capacity. Source Source

The June report said resources should support at least the next twelve months from its August 6 filing date. That is management’s forward assessment; the static calculation above is a separate historical sensitivity. The next cash-flow statement is the evidence that will show whether collections and gross profit are reducing funding needs. New equity can preserve the balance even when the underlying burn has not improved.

The guidance arithmetic makes the size of the required change visible. The August 6 release frames the $32–36 million annual range as “($8.0) – ($9.0) million per quarter, on average”. Because the first half already consumed a calculated $21.290 million, the remaining two quarters would need to average roughly $5.4–7.4 million each to land inside the range, compared with $10.266 million in the March quarter and $11.024 million in the June quarter (Merlintrader calculations). Management linked the expected decline to revenue and margins ramping in the third and fourth quarters after hiring in the Aerospace and Defense division and roughly $0.9 million of second-quarter capital expenditure. Source

06 Financing, equipment obligations and the cost of flexibility

Palladyne is not carrying the type of large bond maturity that dominates some defense-growth companies. It nevertheless has obligations. At June 30, 2026, the notes to the balance sheet reported $1.372 million of noncurrent equipment-financing liabilities (inside other non-current liabilities of $2.925 million, which also include $1.553 million of contingent acquisition consideration), together with $1.196 million of current and $9.361 million of noncurrent operating-lease liabilities. Management’s description of having no significant debt should not be simplified into having no financial commitments. Source

The more immediate funding mechanism is equity. During the first half of 2026, the company sold 2,531,336 shares through its Jefferies ATM program for approximately $17.8 million gross. The June report stated cumulative ATM sales of 10,653,920 shares and approximately $73.3 million gross through the reported period. These are completed sales, not an undrawn credit facility or a promise that the same capital will remain available. Source

An ATM allows issuance into the market over time. Its usefulness depends on the share price, market demand, registration capacity and the terms of the sale program. The company can raise money without negotiating a large single financing, but existing holders own a smaller percentage after new shares are issued. Stable liquidity accompanied by a growing denominator is a different outcome from stable liquidity funded by customer receipts.

The January 9, 2026 resale registration concerned up to 8,365,446 shares associated with the GuideTech transaction, including shares issued at closing and possible earnout shares. The prospectus states that Palladyne would receive no proceeds from selling-stockholder resales. That registration is therefore not additional cash available to finance operations. Potential earnout issuance remains dependent on the contractual conditions and the choice of cash or stock settlement. Source

The acquisition terms summarized in the June 2026 report allow up to $25 million of earnout payments over five years if revenue targets are achieved, payable in cash or shares. Success can thus create an additional claim on cash or an additional source of dilution. The aggregate consideration of $22.6 million comprised $5.4 million of cash, $15.9 million in 2,672,013 common shares and contingent consideration initially valued at $1.4 million; that fair value stood at $1.553 million on June 30. The earnout is therefore a cost that rises with the acquired businesses’ success rather than a liability that is automatically negative. Source

Current funding depends primarily on equity issuance. Operating progress needs to reduce that dependence; a future borrowing agreement would change both the funding structure and the obligations or covenants attached to it. Contract requirements and manufacturing commitments remain relevant even when conventional financial debt is modest. Source

07 Shares, awards and what expired in September

Palladyne had 49,143,403 common shares issued and outstanding at June 30, 2026, up from 46,117,164 at December 31, 2025. The later cover-page count was 49,338,510 at July 29, 2026. The latter is the more recent company-reported count, while neither number is the exact count on October 5. The balance sheet authorized 165 million common shares at June 30; authorization is capacity, not an announcement that all of it will be issued. Source

The legacy deSPAC warrants had a contractual expiration of September 24, 2026 at 5 p.m. New York time. At June 30, 2026 there were 20,549,453 of these warrants outstanding; each was exercisable for one-sixth of a share at $11.50 per warrant, equivalent to roughly 3.42 million shares at about $69 per share (Merlintrader calculation), far above any recent trading price. Nasdaq signed the Form 25 removing the warrant class from listing on September 25, 2026 and it was filed on EDGAR on September 28. The form covers the warrant class only; it does not concern the PDYN common shares. With the deadline passed, the warrants are no longer a source of future exercise or dilution. Source Source

That event did not eliminate all warrant exposure. At June 30, 2026, 430,105 separate warrants from the 2024 insider placement remained outstanding with a $2.30 exercise price and a five-and-a-half-year life from their November 2024 issuance. These are a different instrument from the deSPAC warrants. Any later exercise would need its own evidence; their reported June balance is not a statement that they were all exercised or all extinguished in September. Source

A second legacy instrument reached its deadline on the same date. Under the 2021 merger, former Sarcos holders could receive up to 4,687,500 earn-out shares; half lapsed in September 2025, and the remaining 2,343,750 were still “potentially issuable” at June 30, 2026, but only if the common stock closed at or above $120.00 for 20 trading days in any 30 consecutive trading-day period between the first and fifth anniversaries of the closing, the latter falling on September 24, 2026. The shares traded around $5 in late September. On Merlintrader’s reading the condition can no longer be met; the company had not yet confirmed the lapse in a filing as of October 5. Source Source

Equity compensation is a larger overhang. At June 30, 2026, reported options totaled 1,092,586 and outstanding RSUs totaled 7,206,072. The RSU total already includes the 2025 executive awards (5,360,659 units) approved by shareholders at the June 2026 annual meeting; adding those executive awards again would double count them. At June 30 the company also reported approximately $40.1 million of stock-based compensation cost not yet recognized, to be expensed over a weighted average of 2.8 years. The report also listed 1.5 million restricted stock awards. These categories should not be indiscriminately added to the common-share count, because issued restricted shares and rights to future shares are not the same thing. Source

The executive program covers approximately 5.4 million units, subject to market and service conditions. Its price milestones require sustained performance over 60 consecutive trading days, and unmet tranches are forfeited after November 15, 2030. This is potential dilution conditioned on outcomes, not immediate issuance of the headline amount. Expense recognition and eventual settlement also need not occur at the same time. Source

At the same June 2026 meeting shareholders approved an amendment adding 4,500,000 shares to the 2021 Equity Incentive Plan, which now allows 9.5 million shares plus qualifying recycled legacy awards (capped at 2.1 million), with approximately 5.9 million shares available for grants at June 30. That disclosed reserve, not an assumed automatic annual increase, is the measurable pool. The economic question is whether growth in the business exceeds growth in the claims on it; a rising revenue chart alone cannot answer that. Source

08 Partnerships and contracts: which developments change the numbers

The September 8, 2026 FANUC America collaboration focuses on adapting Palladyne IQ to FANUC industrial robots and validating customer applications; the release lists AI-driven motion planning, teleoperation and human-assisted learning, simulation-based model training and standardized deployment workflows for system integrators. It offers a route into manufacturing and logistics. The announcement describes development and commercial cooperation, without a quantified purchase commitment or revenue timetable. Its next meaningful financial evidence would be paid adoption and repeat deployment. Source

The August 26, 2026 NORDA agreement concerns planned integration of SwarmOS with NORDA’s Underdog autonomy module on one or more unmanned platforms and a joint demonstration, “subject to any necessary governmental approvals”. NORDA Dynamics, founded in 2024, is headquartered in Estonia with an engineering and operations center in Lviv, Ukraine. No timetable or financial terms were given. The parties’ claims about their own technology do not establish the performance or economics of the future combined system. For this hub, the relevant distinction is between an integration program and an order that contributes a specified amount to backlog. Source

Orkid’s August 19, 2026 partnership extends Palladyne Pilot and SwarmOS to Orkid Tech’s fixed-wing VTOL drones for defense and commercial markets such as energy, wildfire management and public safety. Orkid is based in Orlando, Florida. Chief executive Ben Wolff called it “our first partnership focused on bringing SwarmOS to fixed-wing aircraft”. The announcement identifies a commercialization route, not a contract value. Broader platform compatibility may help distribution, but integration costs and customer decisions still determine the eventual return. Source

Those collaborations sit beside identifiable funded work. The August 6 results release cited $2.6 million of BRAIN computer orders, including a $2.3 million counter-UAS-related contract; commencement of the previously announced $4.2 million HANGTIME contract; and a $2.9 million STRATFI option exercise that brought that program above $10.6 million. These figures describe different scopes and stages. They should not all be added to the reported June backlog as though every announcement represented newly booked incremental work. Source

BRAIN gained a test venue on October 6, 2026. Palladyne AI said its edge AI flight computer was selected as a finalist in the U.S. Army FUZE xTech|Apex Intercept competition, delivered with Capability Program Executive Defensive Fires and focused on low-cost interceptor and fire-control technologies. As a finalist the company will demonstrate BRAIN to Army and Department of War end-users at a finals event expected in October or November 2026. Source → The release discloses no prize amount and no contract; a finalist slot is an evaluation opportunity, and the funded BRAIN orders remain the $2.6 million cited in August.

The IAI arrangement is a memorandum of understanding announced on June 8, 2026 with Israel Aerospace Industries, which is wholly owned by the government of Israel. It gives Palladyne the exclusive right to manufacture and market the HAROP, HARPY and Mini-HARPY loitering munitions to the U.S. government, but the intellectual-property licence is subject to a more extensive definitive implementation agreement. To keep the rights Palladyne must establish and operate a U.S. assembly line “at its sole cost and expense” and pay IAI a market-rate royalty on sales; no other up-front royalty is due. The MOU does not prevent the government of Israel from selling the systems directly to the U.S. government, and the cooperation may last up to ten years “subject to achievement of certain milestones”. The 10-Q warns that these investments may be required substantially in advance of meaningful revenue. Those rights can expand the opportunity set without constituting a government procurement award. Source Source The financial progression to watch is customer commitment, manufacturing readiness, delivery obligations and cash collection. A large potential market becomes useful to valuation only when the supplier’s share of that market has credible economics. Source

For an announcement to materially strengthen the thesis, it should reveal more than a partner’s name. The useful details are committed scope, customer funding, delivery timing, expected recognition and the resources needed to perform. A program can be strategically attractive while still increasing near-term burn. Treating every favorable announcement as immediately accretive would miss that tradeoff.

A new development partnership was announced on October 7, 2026. With Federal Ammunition and Mossberg, Palladyne launched SwarmShot, a modular airborne counter-drone system intended to turn compatible drones into reusable interceptors that act as a swarm. Palladyne provides the Gremlin-X Group 1 quadcopter and its IntelliSwarm autonomy combining BRAIN avionics and SwarmOS, plus integration and fire control; Federal handles the ammunition and Mossberg the weapon module. The release discloses no funding, revenue share, timeline or customer, so like the other development programs in this chapter it shows technical positioning rather than contracted revenue. Company release

09 Catalyst calendar and the questions for the next results

The next financial checkpoint is the report for the quarter ended September 30, 2026. A precise earnings-release date is not established by the cited announcements and is not assigned here. The August 6 outlook expected sequential revenue growth in that quarter and declining burn through the second half. Those are the conditions to test when the results arrive. As of October 5, 2026 no results date or conference-call notice had been published; for the June quarter the call announcement came on July 23, two weeks before the August 6 report. Source Source

The revenue question is whether deliveries advance at a pace consistent with the annual outlook. The cash question is whether the reported burn begins to approach the lower pace implied for the second half. The financing question is how much of the cash balance comes from customer receipts and how much comes from additional shares. Read together, those answers show whether a growing order book is producing a more sustainable company.

On August 6, 2026, Palladyne said it had invitations to five further military exercises through March 2027. That is a participation window, not a timetable for five contract awards. Demonstration success can improve access to procurement decisions, while the separate award process and budget determine revenue. The first of those exercises, Northern Strike, was already underway when the company reported on August 6, so it belongs to the past rather than to the forward calendar. Source

The partnership catalysts are less precisely dated. FANUC customer validation, NORDA integration and approvals, and Orkid deployment work can create useful updates. None of their cited releases supplies a date, a value or a purchase commitment. In Merlintrader’s reading, the informative update would be a disclosed milestone with a financial implication rather than a calendar date inferred from a press release. The company had announced that management was scheduled to take part in a fireside chat at the Jefferies Global Industrials Conference on September 9 and in one-on-one investor meetings at Lake Street’s BIG10 conference on September 10; no new financial data were filed with the SEC around those dates. Source Source Source

At the next results, the most informative management explanation would connect a specific delivery to recognition, collection and remaining work. If revenue rises but unbilled receivables expand faster, the cash benefit may still lie ahead. If cash improves mainly after an ATM sale, funding risk has been postponed rather than resolved. If software sales emerge, their contract structure and contribution deserve attention before assuming recurring revenue.

10 Float, short positioning, owners and insider activity

BlackRock Portfolio Management LLC’s Schedule 13G/A dated October 5, 2026 reports 591,330 beneficially owned shares, or 1.2%, as of September 30. This is a later disclosure from that filer than the January position discussed below. The filing expressly excludes separately reported BlackRock business units, so it cannot establish BlackRock’s aggregate holdings or be mechanically combined with the separate BlackRock Inc. filing. Primary source 1.

PDYN closed at $5.33 on Nasdaq on October 2, 2026, the last session before this update. Multiplied by the 49,338,510 shares on the July 29 cover of the 10-Q, that gives a market value of about $263 million (Merlintrader calculation; shares issued after July 29 are not included). Source Source

Nasdaq reported short interest of 6,448,148 shares at the September 15, 2026 settlement date, about 13.1% of the July 29 share count (Merlintrader calculation) and equal to 9.8 days to cover on Nasdaq’s figures. The position has been shrinking: 8,332,776 shares at June 30, 9,222,861 at July 15, 8,688,831 at July 31, 7,922,145 at August 14 and 7,725,205 at August 31, a decline of about 30% from the mid-July peak. Short interest is published twice a month with a lag, so each figure describes the position on its settlement date only. Source

Days to cover relates reported short shares to recent daily trading activity, as calculated by Nasdaq. It is not a deadline by which positions must be covered, and it does not reveal borrowing costs or the current availability of shares. Substantial short positioning can intensify a reaction to a real contract or financing surprise in either direction. It does not substitute for the operating evidence.

Filed ownership data give a narrower but verifiable picture. No aggregate insider or institutional percentage is filed with the SEC, so none is given here; the disclosures below each carry their own date and denominator.

A specific insider action is clearer. CEO Benjamin Wolff reported buying 17,121 common shares on September 8, 2026 at a weighted average price of $5.7899 through Mare’s Leg Capital, an entity owned with his spouse. The reported purchase value is approximately $99,100, calculated from those inputs. The individual trades were executed between $5.75 and $5.84. This was an actual purchase, not a tax-withholding disposal or an award grant. After it, the Form 4 shows 7,308,343 shares held directly, 400,240 through Mare’s Leg Capital, 107,526 through a 401(k) trust and 904 by his spouse, 7,817,013 in total or about 15.8% of the July 29 share count (Merlintrader calculation; directly held shares can include restricted stock). It indicates additional personal exposure, but it cannot validate a future sales forecast. Source

Earlier, on August 21, 2026, chief technology officer Denis Garagic, chief legal officer Stephen Sonne and chief financial officer Trevor Thatcher reported sales of 17,255, 5,341 and 4,636 shares respectively at a weighted average of $6.1589. Each Form 4 states that the shares were sold to cover income-tax liabilities on vesting restricted stock units under a sell-to-cover arrangement and “does not represent discretionary transactions”. Source Source Source

William Kerber’s May 14, 2026 Schedule 13D amendment reported 2,366,314 beneficially owned shares, 5.0% of the 47,244,225 shares on the May 5 10-Q cover. It included a May 13 purchase of 10,000 shares at $6.76 and gifts of 250,000 shares on May 5 and 8 to a family trust over which he retains shared voting and dispositive power; the gifts were not open-market sales. Two separate BlackRock filings exist and they come from different filers. The April 2026 proxy lists BlackRock Portfolio Management LLC with 3,042,065 shares (6.4%), based on its Schedule 13G/A filed on January 21, 2026. BlackRock, Inc. then filed a Schedule 13G on July 29, 2026 reporting 2,554,513 shares, 5.4% of the class, as of June 30, 2026; that filing covers only certain BlackRock business units. The two figures are not a like-for-like series, so they do not by themselves show a change in BlackRock’s position. These are dated disclosures, not estimates of holdings on October 5. Source Source Source Source

Ownership matters most when read alongside the share count and compensation structure. Management can increase its exposure while the company also issues new shares to finance operations. Both statements can be true. The relevant question for an outside shareholder remains how much operating value is created for each additional claim on the business.

11 Red flags and the evidence that would change the reading

The main risk is commercialization outrunning financial capacity. Palladyne has expanded its addressable work, but engineering and manufacturing consume resources before the eventual margin is known. A contract that looks attractive at award can produce disappointing cash flow if execution requires more staff, materials or time than anticipated. Fixed-price work is particularly sensitive to that mismatch, while government-funded activity can face changes in scope and timing. Source

The second risk is mistaking corporate growth for progress per share. Acquisitions added real businesses, and the ATM added real cash. They also brought integration costs, contingent consideration and a larger equity base. A favorable operating update should therefore improve the relationship between revenue, cash use and shares, rather than just provide a larger consolidated total.

The third risk is assigning software economics before there is software product revenue. The June 2026 statement of no software product sales is material because it changes the evidence required for the valuation narrative. Paid development is valuable, but repeat commercial licensing would be a different achievement. The thesis strengthens when customer adoption becomes visible in revenue and cash, not merely in the number of cooperating platforms. Source

A final risk is headline classification. A military exercise is not an award, a collaboration is not a quantified order, an option is not exercised backlog, a resale registration does not fund the company, and the removal of an expired warrant does not delist the common stock. Those distinctions determine what an announcement actually changes for a trader.

In Merlintrader’s reading, the central question is the conversion of existing work into revenue and cash, measured against the financing required to get there. Palladyne has a broader operating base and several credible routes to commercialization. The decisive next evidence is a faster delivery pace with lower burn and manageable dilution. Until those elements improve together, commercial opportunity and financial robustness remain separate questions.